Arkolith/Insider Trading/MDGL/Form 4

Dier Mardi

EVP and CFOMADRIGAL PHARMACEUTICALS, INC. (MDGL) · full profile →Form 4 · filed Mar 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$854K
Net Open-Market Flow
-$854K
Transactions
14
13 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2026Sell(S)160$434.20$69K13K
Mar 6, 2026Sell(S)80$435.32$35K13K
Mar 6, 2026Sell(S)80$436.69$35K13K
Mar 6, 2026Sell(S)40$437.65$18K12K
Mar 6, 2026Sell(S)120$430.90$52K13K
Mar 6, 2026Sell(S)116$432.56$50K13K
Mar 6, 2026Sell(S)646$431.94$279K14K
Mar 6, 2026Sell(S)40$425.08$17K14K
Mar 6, 2026Sell(S)420$426.86$179K13K
Mar 6, 2026Sell(S)80$427.85$34K13K
Mar 6, 2026Sell(S)160$429.00$69K13K
Mar 6, 2026Sell(S)40$429.58$17K13K
Mar 4, 2026Grant(A)5K—$014K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Grant(A)7K—$07K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015775) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML